Influenza B Vaccine Strain Confirmed By FDA Committee
This article was originally published in The Pink Sheet Daily
A Yamagata lineage strain should replace a Victoria lineage strain in the 2004-2005 vaccine, the committee says.
You may also be interested in...
FDA committee recommends switch from a Victoria to a Yamagata lineage influenza B strain. For influenza A, New Caledonia (H1N1) strain will be retained, while a Fujian-like strain will replace this season's Panama-like strain.
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said